Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
BRBI vs PX vs JPM vs BAC vs GS
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Banks - Diversified
Banks - Diversified
Financial - Capital Markets
BRBI vs PX vs JPM vs BAC vs GS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Banks - Diversified | Banks - Diversified | Financial - Capital Markets |
| Market Cap | $913M | $909M | $869.15B | $404.74B | $331.89B |
| Revenue (TTM) | $7.41B | $8.99B | $280.33B | $191.57B | $125.10B |
| Net Income (TTM) | $194M | $1.55B | $57.05B | $30.51B | $17.18B |
| Gross Margin | 5.9% | 48.2% | 60.0% | 56.1% | 47.5% |
| Operating Margin | 3.2% | 23.0% | 25.9% | 19.7% | 17.5% |
| Forward P/E | 24.4x | 6.9x | 14.0x | 12.0x | 17.6x |
| Total Debt | $9.93B | $26.99B | $942.38B | $365.90B | $609.53B |
| Cash & Equiv. | $575M | $5.06B | $343.34B | $231.84B | $164.26B |
BRBI vs PX vs JPM vs BAC vs GS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 25 | Jun 26 | Return |
|---|---|---|---|
| BRBI BR Partners S.… (BRBI) | 100 | 87.0 | -13.0% |
| P10, Inc. (PX) | 100 | 64.6 | -35.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 183.1 | +83.1% |
| Bank of America Cor… (BAC) | 100 | 112.2 | +12.2% |
| The Goldman Sachs G… (GS) | 100 | 252.8 | +152.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRBI vs PX vs JPM vs BAC vs GS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRBI has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- Efficiency ratio 0.0% vs BAC's 0.4% (lower = leaner)
- Efficiency ratio 0.0% vs BAC's 0.4%
PX is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 113.6%, EPS growth 90.3%
- PEG 0.05 vs GS's 1.26
- 113.6% NII/revenue growth vs GS's -1.4%
- Lower P/E (6.9x vs 17.6x), PEG 0.05 vs 1.26
JPM is the clearest fit if your priority is bank quality.
- NIM 2.2% vs GS's 0.7%
BAC ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.89, yield 2.4%
- Lower volatility, beta 0.89, current ratio 0.42x
- Beta 0.89, yield 2.4%, current ratio 0.42x
- Beta 0.89 vs PX's 1.98
GS is the clearest fit if your priority is long-term compounding.
- 6.3% 10Y total return vs JPM's 433.9%
- +73.1% vs PX's -22.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 113.6% NII/revenue growth vs GS's -1.4% | |
| Value | Lower P/E (6.9x vs 17.6x), PEG 0.05 vs 1.26 | |
| Quality / Margins | Efficiency ratio 0.0% vs BAC's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.89 vs PX's 1.98 | |
| Dividends | 2.4% yield, 12-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +73.1% vs PX's -22.1% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs BAC's 0.4% |
BRBI vs PX vs JPM vs BAC vs GS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRBI vs PX vs JPM vs BAC vs GS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 1 of 6 categories
BAC leads 1 • PX leads 1 • GS leads 1 • BRBI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 37.8x BRBI's $7.4B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to BRBI's 2.6%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7.4B | $9.0B | $280.3B | $191.6B | $125.1B |
| EBITDAEarnings before interest/tax | — | $3.0B | $81.4B | $40.0B | $24.0B |
| Net IncomeAfter-tax profit | — | $1.6B | $57.0B | $30.5B | $17.2B |
| Free Cash FlowCash after capex | — | $1.6B | $100.9B | $12.6B | -$47.2B |
| Gross MarginGross profit ÷ Revenue | +5.9% | +48.2% | +60.0% | +56.1% | +47.5% |
| Operating MarginEBIT ÷ Revenue | +3.2% | +23.0% | +25.9% | +19.7% | +17.5% |
| Net MarginNet income ÷ Revenue | +2.6% | +17.3% | +20.4% | +15.9% | +13.7% |
| FCF MarginFCF ÷ Revenue | +1.2% | +17.7% | +36.0% | +6.6% | -37.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +103.0% | +16.0% | +18.3% | +45.8% |
Valuation Metrics
BAC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 14.0x trailing earnings, BAC trades at a 70% valuation discount to PX's 47.2x P/E. Adjusting for growth (PEG ratio), PX offers better value at 0.35x vs GS's 1.45x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $913M | $909M | $869.1B | $404.7B | $331.9B |
| Enterprise ValueMkt cap + debt − cash | $2.7B | $1.2B | $1.47T | $538.8B | $777.2B |
| Trailing P/EPrice ÷ TTM EPS | 24.43x | 47.19x | 15.52x | 14.04x | 20.36x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 6.92x | 13.97x | 12.02x | 17.63x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.35x | 1.19x | 0.91x | 1.45x |
| EV / EBITDAEnterprise value multiple | 57.04x | 13.56x | 18.03x | 13.47x | 32.34x |
| Price / SalesMarket cap ÷ Revenue | 0.64x | 3.07x | 3.11x | 2.11x | 2.65x |
| Price / BookPrice ÷ Book value/share | 5.88x | 2.35x | 2.40x | 1.33x | 2.66x |
| Price / FCFMarket cap ÷ FCF | 54.18x | 9.41x | 8.62x | 32.09x | — |
Profitability & Efficiency
PX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BRBI delivers a 23.8% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $10 for BAC. PX carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRBI's 12.34x. On the Piotroski fundamental quality scale (0–9), PX scores 7/9 vs GS's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +23.8% | +15.2% | +15.9% | +10.1% | +13.6% |
| ROA (TTM)Return on assets | +1.5% | +6.9% | +1.3% | +0.9% | +1.0% |
| ROICReturn on invested capital | +2.0% | +19.8% | +4.5% | +3.5% | +2.2% |
| ROCEReturn on capital employed | +2.3% | +24.6% | +8.9% | +4.5% | +4.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 5 | 7 | 4 |
| Debt / EquityFinancial leverage | 12.34x | 0.68x | 2.60x | 1.21x | 4.88x |
| Net DebtTotal debt minus cash | $9.4B | $21.9B | $599.0B | $134.1B | $445.3B |
| Cash & Equiv.Liquid assets | $575M | $5.1B | $343.3B | $231.8B | $164.3B |
| Total DebtShort + long-term debt | $9.9B | $27.0B | $942.4B | $365.9B | $609.5B |
| Interest CoverageEBIT ÷ Interest expense | — | 315.20x | 0.74x | 0.48x | 0.33x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $28,672 today (with dividends reinvested), compared to $6,730 for PX. Over the past 12 months, GS leads with a +73.1% total return vs PX's -22.1%. The 3-year compound annual growth rate (CAGR) favors GS at 47.9% vs PX's -11.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -15.5% | -22.9% | -3.5% | -3.1% | +15.3% |
| 1-Year ReturnPast 12 months | — | -22.1% | +18.8% | +22.0% | +73.1% |
| 3-Year ReturnCumulative with dividends | — | -30.4% | +131.9% | +94.2% | +223.4% |
| 5-Year ReturnCumulative with dividends | — | -32.7% | +102.6% | +36.4% | +186.7% |
| 10-Year ReturnCumulative with dividends | +41470.8% | -32.7% | +433.9% | +324.7% | +625.6% |
| CAGR (3Y)Annualised 3-year return | — | -11.4% | +32.4% | +24.8% | +47.9% |
Risk & Volatility
Evenly matched — BAC and GS each lead in 1 of 2 comparable metrics.
Risk & Volatility
BAC is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than PX's 1.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GS currently trades 95.4% from its 52-week high vs BRBI's 17.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.02x | 1.98x | 0.95x | 0.89x | 1.57x |
| 52-Week HighHighest price in past year | $67.01 | $13.08 | $337.25 | $57.55 | $1095.89 |
| 52-Week LowLowest price in past year | $0.00 | $6.97 | $262.71 | $43.66 | $609.31 |
| % of 52W HighCurrent price vs 52-week peak | +17.3% | +57.7% | +92.2% | +93.2% | +95.4% |
| RSI (14)Momentum oscillator 0–100 | 33.6 | 31.9 | 59.6 | 62.7 | 60.2 |
| Avg Volume (50D)Average daily shares traded | 2K | 690K | 7.1M | 32.3M | 1.9M |
Analyst Outlook
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PX as "Buy", JPM as "Buy", BAC as "Buy", GS as "Hold". Consensus price targets imply 231.1% upside for PX (target: $25) vs -6.1% for GS (target: $981). For income investors, BAC offers the higher dividend yield at 2.36% vs GS's 1.59%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $25.00 | $338.78 | $61.13 | $980.78 |
| # AnalystsCovering analysts | — | 8 | 61 | 54 | 55 |
| Dividend YieldAnnual dividend ÷ price | — | +1.7% | +1.9% | +2.4% | +1.6% |
| Dividend StreakConsecutive years of raises | 1 | 4 | 15 | 12 | 14 |
| Dividend / ShareAnnual DPS | — | $5.95 | $5.95 | $1.27 | $16.62 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +7.5% | +4.0% | +5.3% | +3.7% |
JPM leads in 1 of 6 categories (Income & Cash Flow). BAC leads in 1 (Valuation Metrics). 2 tied.
BRBI vs PX vs JPM vs BAC vs GS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRBI or PX or JPM or BAC or GS a better buy right now?
For growth investors, P10, Inc.
(PX) is the stronger pick with 113. 6% revenue growth year-over-year, versus -1. 4% for The Goldman Sachs Group, Inc. (GS). Bank of America Corporation (BAC) offers the better valuation at 14. 0x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate P10, Inc. (PX) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRBI or PX or JPM or BAC or GS?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
0x versus P10, Inc. at 47. 2x. On forward P/E, P10, Inc. is actually cheaper at 6. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: P10, Inc. wins at 0. 05x versus The Goldman Sachs Group, Inc. 's 1. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BRBI or PX or JPM or BAC or GS?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +186. 7%, compared to -32. 7% for P10, Inc. (PX). Over 10 years, the gap is even starker: BRBI returned +414. 7% versus PX's -32. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRBI or PX or JPM or BAC or GS?
By beta (market sensitivity over 5 years), Bank of America Corporation (BAC) is the lower-risk stock at 0.
89β versus P10, Inc. 's 1. 98β — meaning PX is approximately 123% more volatile than BAC relative to the S&P 500. On balance sheet safety, P10, Inc. (PX) carries a lower debt/equity ratio of 68% versus 12% for BRBI BR Partners S. A. ADSs — giving it more financial flexibility in a downturn.
05Which is growing faster — BRBI or PX or JPM or BAC or GS?
By revenue growth (latest reported year), P10, Inc.
(PX) is pulling ahead at 113. 6% versus -1. 4% for The Goldman Sachs Group, Inc. (GS). On earnings-per-share growth, the picture is similar: P10, Inc. grew EPS 90. 3% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRBI or PX or JPM or BAC or GS?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 2. 6% for BRBI BR Partners S. A. ADSs — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PX leads at 26. 3% versus 3. 2% for BRBI. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRBI or PX or JPM or BAC or GS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, P10, Inc. (PX) is the more undervalued stock at a PEG of 0. 05x versus The Goldman Sachs Group, Inc. 's 1. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, P10, Inc. (PX) trades at 6. 9x forward P/E versus 17. 6x for The Goldman Sachs Group, Inc. — 10. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PX: 231. 1% to $25. 00.
08Which pays a better dividend — BRBI or PX or JPM or BAC or GS?
In this comparison, BAC (2.
4% yield), JPM (1. 9% yield), PX (1. 7% yield), GS (1. 6% yield) pay a dividend. BRBI does not pay a meaningful dividend and should not be held primarily for income.
09Is BRBI or PX or JPM or BAC or GS better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 95), 1. 9% yield, +433. 9% 10Y return). P10, Inc. (PX) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +433. 9%, PX: -32. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRBI and PX and JPM and BAC and GS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BRBI is a small-cap quality compounder stock; PX is a small-cap high-growth stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; GS is a large-cap quality compounder stock. PX, JPM, BAC, GS pay a dividend while BRBI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.